AngioDynamics Dialysis Catheter Portfolio & BioSentry Biopsy Tract Sealant System - Ownership and Business Overview

Medical ProductsCompany

AngioDynamics Dialysis Catheter Portfolio & BioSentry Biopsy Tract Sealant System Ownership

Who owns AngioDynamics Dialysis Catheter Portfolio & BioSentry Biopsy Tract Sealant System?

AngioDynamics Dialysis Catheter Portfolio & BioSentry Biopsy Tract Sealant System is owned by Merit Medical Systems. It was acquired on June 8, 2023.

AngioDynamics Dialysis Catheter Portfolio & BioSentry Biopsy Tract Sealant System Business Overview

Where is AngioDynamics Dialysis Catheter Portfolio & BioSentry Biopsy Tract Sealant System headquartered?

AngioDynamics Dialysis Catheter Portfolio & BioSentry Biopsy Tract Sealant System is headquartered in Latham, New York.

What sector is AngioDynamics Dialysis Catheter Portfolio & BioSentry Biopsy Tract Sealant System in?

AngioDynamics Dialysis Catheter Portfolio & BioSentry Biopsy Tract Sealant System is a medical products company.

Medical Products M&A Summary in 2023

Out of 60 sectors in the Mergr database, medical products ranked 13 in number of deals in 2023. The largest medical products acquisition in 2023 was Medit - which was acquired by Unison Capital for $2.1B.

Join Mergr to view all 140 acquisitions of medical products companies in 2023, including 22 acquisitions by private equity firms, and 118 by strategics.

AngioDynamics' Dialysis Catheter Portfolio & BioSentry Biopsy Tract Sealant System

AngioDynamics - Dialysis Catheter Portfolio & BioSentry Biopsy Tract Sealant System

Latham, New York
United States,

AngioDynamics' Dialysis Catheter Portfolio & BioSentry Biopsy Tract Sealant System provides dialysis catheter products.


 Subscribe to unlock this and 208,055
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.6K Private Equity Firms
  • 201K M&A Transactions
  • 203K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.6K M&A Advisors
    (Investment Banks and Law Firms)
  • 81K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.